{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:26:00Z","timestamp":1793496360190,"version":"4.5.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02719-y","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:27:21Z","timestamp":1759843641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Lipid accumulation product and visceral adiposity index in polycystic ovary syndrome: a systematic review and meta-analysis of observational studies"],"prefix":"10.1186","volume":"24","author":[{"given":"Mohammadamin","family":"Parsaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaheh","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirali","family":"Barkhordarioon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Tarafdari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"issue":"3","key":"2719_CR1","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00404-024-07607-x","volume":"310","author":"N Salari","year":"2024","unstructured":"Salari N, Nankali A, Ghanbari A, Jafarpour S, Ghasemi H, Dokaneheifard S, et al. Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis. Arch Gynecol Obstet. 2024;310(3):1303\u201314.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"2719_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"TR Eshre","year":"2004","unstructured":"Eshre TR, Group A-SPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325.","journal-title":"Fertil Steril."},{"issue":"12","key":"2719_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3390\/metabo11120869","volume":"11","author":"W Chen","year":"2021","unstructured":"Chen W, Pang Y. Metabolic syndrome and PCOS: pathogenesis and the role of metabolites. Metabolites. 2021;11(12):869.","journal-title":"Metabolites"},{"issue":"8","key":"2719_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084110","volume":"23","author":"D Armanini","year":"2022","unstructured":"Armanini D, Boscaro M, Bordin L, Sabbadin C. Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism. Int J Mol Sci. 2022;23(8):4110.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2719_CR5","first-page":"89","volume":"26","author":"AT Ali","year":"2022","unstructured":"Ali AT, Al-Ani O, Al-Ani F, Guidozzi F. Polycystic ovary syndrome and metabolic disorders: a review of the literature. Afr J Reprod Health. 2022;26(8):89\u201399.","journal-title":"Afr J Reprod Health"},{"issue":"1","key":"2719_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","volume":"16","author":"H Zhao","year":"2023","unstructured":"Zhao H, Zhang J, Cheng X, Nie X, He B. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res. 2023;16(1):9.","journal-title":"J Ovarian Res"},{"issue":"2","key":"2719_CR7","first-page":"604","volume":"102","author":"M Gibson-Helm","year":"2017","unstructured":"Gibson-Helm M, Teede H, Dunaif A, Dokras A. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2017;102(2):604\u201312.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2719_CR8","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1210\/js.2018-00181","volume":"2","author":"AW Lin","year":"2018","unstructured":"Lin AW, Bergomi EJ, Dollahite JS, Sobal J, Hoeger KM, Lujan ME. Trust in physicians and medical experience beliefs differ between women with and without polycystic ovary syndrome. J Endocr Soc. 2018;2(9):1001\u20139.","journal-title":"J Endocr Soc"},{"issue":"9","key":"2719_CR9","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1093\/humrep\/dew174","volume":"31","author":"I Rowlands","year":"2016","unstructured":"Rowlands I, Teede H, Lucke J, Dobson A, Mishra G. Young women\u2019s psychological distress after a diagnosis of polycystic ovary syndrome or endometriosis. Hum Reprod. 2016;31(9):2072\u201381.","journal-title":"Hum Reprod"},{"issue":"1","key":"2719_CR10","first-page":"173281","volume":"2012","author":"S-K Xiang","year":"2012","unstructured":"Xiang S-K, Hua F, Tang Y, Jiang X-H, Zhuang Q, Qian F-J. Relationship between serum lipoprotein ratios and insulin resistance in polycystic ovary syndrome. Int J Endocrinol. 2012;2012(1):173281.","journal-title":"Int J Endocrinol"},{"issue":"2","key":"2719_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/17425255.2022.2071259","volume":"18","author":"AS Lagan\u00e0","year":"2022","unstructured":"Lagan\u00e0 AS, Forte G, Bizzarri M, Kamenov ZA, Bianco B, Kaya C, et al. Inositols in the ovaries: activities and potential therapeutic applications. Expert Opin Drug Metab Toxicol. 2022;18(2):123\u201333.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"2719_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1017\/S0954422416000287","volume":"30","author":"YM Jeanes","year":"2017","unstructured":"Jeanes YM, Reeves S. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. Nutr Res Rev. 2017;30(1):97\u2013105.","journal-title":"Nutr Res Rev"},{"key":"2719_CR13","doi-asserted-by":"publisher","first-page":"1091147","DOI":"10.3389\/fendo.2022.1091147","volume":"13","author":"C Tong","year":"2022","unstructured":"Tong C, Wu Y, Zhang L, Yu Y. Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: association with PI3K signaling pathway. Front Endocrinol. 2022;13:1091147.","journal-title":"Front Endocrinol"},{"issue":"12","key":"2719_CR14","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jcmg.2014.07.017","volume":"7","author":"RV Shah","year":"2014","unstructured":"Shah RV, Murthy VL, Abbasi SA, Blankstein R, Kwong RY, Goldfine AB, et al. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC Cardiovasc Imaging. 2014;7(12):1221\u201335.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"2719_CR15","first-page":"23","volume":"49","author":"GA Abruzzese","year":"2017","unstructured":"Abruzzese GA, Cerrrone GE, Gamez JM, Graffigna MN, Belli S, Lioy G, et al. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as markers of insulin resistance and metabolic associated disturbances in young argentine women with polycystic ovary syndrome. Horm Metab Res. 2017;49(1):23\u20139.","journal-title":"Horm Metab Res"},{"issue":"2","key":"2719_CR16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4103\/ijem.IJEM_559_18","volume":"23","author":"H Agrawal","year":"2019","unstructured":"Agrawal H, Aggarwal K, Jain A. Visceral adiposity index: simple tool for assessing cardiometabolic risk in women with polycystic ovary syndrome. Indian J Endocrinol Metab. 2019;23(2):232\u20137.","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"2719_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1210\/clinem\/dgad356","volume":"109","author":"F Bril","year":"2024","unstructured":"Bril F, Ezeh U, Amiri M, Hatoum S, Pace L, Chen Y-H, et al. Adipose tissue dysfunction in polycystic ovary syndrome. J Clin Endocrinol Metab. 2024;109(1):10\u201324.","journal-title":"J Clin Endocrinol Metab"},{"key":"2719_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/nu13113925","author":"L Barrea","year":"2021","unstructured":"Barrea L, Muscogiuri G, Pugliese G, de Alteriis G, Colao A, Savastano S. Metabolically healthy obesity (MHO) vs. metabolically unhealthy obesity (MUO) phenotypes in PCOS: association with endocrine-metabolic profile, adherence to the Mediterranean diet, and body composition. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13113925.","journal-title":"Nutrients"},{"issue":"2","key":"2719_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3390\/metabo13020302","volume":"13","author":"M Jabczyk","year":"2023","unstructured":"Jabczyk M, Nowak J, Jagielski P, Hudzik B, Kulik-Kupka K, W\u0142odarczyk A, et al. Metabolic deregulations in patients with polycystic ovary syndrome. Metabolites. 2023;13(2):302.","journal-title":"Metabolites"},{"key":"2719_CR20","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"8","key":"2719_CR21","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1001\/jamasurg.2021.0522","volume":"156","author":"BS Brooke","year":"2021","unstructured":"Brooke BS, Schwartz TA, Pawlik TM. Moose reporting guidelines for meta-analyses of observational studies. JAMA Surg. 2021;156(8):787\u20138.","journal-title":"JAMA Surg"},{"issue":"3","key":"2719_CR22","doi-asserted-by":"publisher","first-page":"A12","DOI":"10.7326\/ACPJC-1995-123-3-A12","volume":"123","author":"WS Richardson","year":"1995","unstructured":"Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club. 1995;123(3):A12\u20133.","journal-title":"ACP J Club"},{"key":"2719_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2261-5-26","volume":"5","author":"HS Kahn","year":"2005","unstructured":"Kahn HS. The\" lipid accumulation product\" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5:1\u201310.","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"2719_CR24","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2337\/dc09-1825","volume":"33","author":"MC Amato","year":"2010","unstructured":"Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920\u20132.","journal-title":"Diabetes Care"},{"issue":"6","key":"2719_CR25","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785\u2013805.","journal-title":"Stat Methods Med Res"},{"key":"2719_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol"},{"key":"2719_CR27","unstructured":"JBI Checklist for Case-Control Studies. JBI Glob. 2020."},{"issue":"7109","key":"2719_CR28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"449","key":"2719_CR29","first-page":"89","volume":"95","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. A nonparametric \u201ctrim and fill\u201d method of accounting for publication bias in meta-analysis. J Am Stat Assoc. 2000;95(449):89\u201398.","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"2719_CR30","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/s13063-023-07569-6","volume":"24","author":"MS Najafabadi","year":"2023","unstructured":"Najafabadi MS, Moludi J, Salimi Y, Saber A. A comparison of the portfolio low-carbohydrate diet and the ketogenic diet in overweight and obese women with polycystic ovary syndrome: study protocol for a randomized controlled trial. Trials. 2023;24(1):509.","journal-title":"Trials"},{"issue":"4","key":"2719_CR31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","volume":"21","author":"N Helvaci","year":"2025","unstructured":"Helvaci N, Yildiz BO. Polycystic ovary syndrome as a metabolic disease. Nat Rev Endocrinol. 2025;21(4):230\u201344.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"2719_CR32","doi-asserted-by":"publisher","first-page":"E986","DOI":"10.1210\/jc.2011-0031","volume":"96","author":"E Wehr","year":"2011","unstructured":"Wehr E, Gruber HJ, Giuliani A, M\u00f6ller R, Pieber TR, Obermayer-Pietsch B. The lipid accumulation product is associated with impaired glucose tolerance in PCOS women. J Clin Endocrinol Metab. 2011;96(6):E986-90.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2719_CR33","doi-asserted-by":"publisher","first-page":"e114112","DOI":"10.1371\/journal.pone.0114112","volume":"9","author":"S Borruel","year":"2014","unstructured":"Borruel S, Molt\u00f3 JF, Alpa\u00f1\u00e9s M, Fern\u00e1ndez-Dur\u00e1n E, \u00c1lvarez-Blasco F, Luque-Ram\u00edrez M, et al. Surrogate markers of visceral adiposity in young adults: waist circumference and body mass index are more accurate than waist hip ratio, model of adipose distribution and visceral adiposity index. PLoS One. 2014;9(12):e114112.","journal-title":"PLoS One"},{"issue":"12","key":"2719_CR34","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s10815-017-1030-3","volume":"34","author":"LML Carvalho","year":"2017","unstructured":"Carvalho LML, Ferreira CN, de Oliveira DKD, Rodrigues KF, Duarte RCF, Teixeira MFA, et al. Haptoglobin levels, but not Hp1-Hp2 polymorphism, are associated with polycystic ovary syndrome. J Assist Reprod Genet. 2017;34(12):1691\u20138.","journal-title":"J Assist Reprod Genet"},{"issue":"19","key":"2719_CR35","first-page":"7182","volume":"26","author":"M Apaydin","year":"2022","unstructured":"Apaydin M, Kazan ED, Beysel S, Sari A, \u00d6zg\u00fcl E, Cengiz H, et al. The novel predictor of metabolic risk in patients with polycystic ovary syndrome: could it be the visceral adiposity index? Eur Rev Med Pharmacol Sci. 2022;26(19):7182\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"2719_CR36","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1530\/EC-17-0151","volume":"6","author":"SF de Medeiros","year":"2017","unstructured":"de Medeiros SF, Ormond CM, de Medeiros MAS, de Souza SN, Banhara CR, Yamamoto MMW. Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women. Endocr Connect. 2017;6(7):479\u201388.","journal-title":"Endocr Connect"},{"issue":"10","key":"2719_CR37","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1111\/jog.14940","volume":"47","author":"SF de Medeiros","year":"2021","unstructured":"de Medeiros SF, de Medeiros MAS, Barbosa BB, Yamamoto A, Yamamoto MMW. The connection of alpha-1 acid glycoprotein inflammatory marker with anthropometric, hormonal, and metabolic characteristic of women with polycystic ovary syndrome. J Obstet Gynaecol Res. 2021;47(10):3571\u201382.","journal-title":"J Obstet Gynaecol Res"},{"issue":"7","key":"2719_CR38","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/humrep\/dep072","volume":"24","author":"D Wiltgen","year":"2009","unstructured":"Wiltgen D, Benedetto IG, Mastella LS, Spritzer PM. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum Reprod. 2009;24(7):1726\u201331.","journal-title":"Hum Reprod"},{"issue":"6","key":"2719_CR39","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1093\/humrep\/der088","volume":"26","author":"MC Amato","year":"2011","unstructured":"Amato MC, Verghi M, Galluzzo A, Giordano C. The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk. Hum Reprod. 2011;26(6):1486\u201394.","journal-title":"Hum Reprod"},{"issue":"9","key":"2719_CR40","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1055\/s-0032-1309006","volume":"120","author":"FM Mario","year":"2012","unstructured":"Mario FM, do Amarante F, Toscani MK, Spritzer PM. Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance. Exp Clin Endocrinol Diabetes. 2012;120(9):511\u20136.","journal-title":"Exp Clin Endocrinol Diabetes."},{"issue":"4","key":"2719_CR41","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.fertnstert.2013.06.005","volume":"100","author":"SK Graff","year":"2013","unstructured":"Graff SK, M\u00e1rio FM, Alves BC, Spritzer PM. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes. Fertil Steril. 2013;100(4):1081\u20138.","journal-title":"Fertil Steril"},{"issue":"12","key":"2719_CR42","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1210\/jc.2013-2141","volume":"98","author":"PB Lauria","year":"2013","unstructured":"Lauria PB, Del Puerto HL, Reis AM, Candido AL, Reis FM. Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome. J Clin Endocrinol Metab. 2013;98(12):4882\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2719_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1210\/jc.2013-2669","volume":"99","author":"MC Amato","year":"2014","unstructured":"Amato MC, Guarnotta V, Ciresi A, Modica R, Pant\u00f2 F, Giordano C. No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus. J Clin Endocrinol Metab. 2014;99(1):203\u201311.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2719_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/cen.12287","volume":"81","author":"F Hosseinpanah","year":"2014","unstructured":"Hosseinpanah F, Barzin M, Erfani H, Serahati S, Tehrani FR, Azizi F. Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study. Clin Endocrinol. 2014;81(1):52\u20137.","journal-title":"Clin Endocrinol"},{"issue":"4","key":"2719_CR45","doi-asserted-by":"publisher","first-page":"519","DOI":"10.14310\/horm.2002.1493","volume":"13","author":"SA Polyzos","year":"2014","unstructured":"Polyzos SA, Goulis DG, Kountouras J, Mintziori G, Chatzis P, Papadakis E, et al. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis. Hormones (Athens). 2014;13(4):519\u201331.","journal-title":"Hormones (Athens)"},{"issue":"2","key":"2719_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1530\/EJE-14-0094","volume":"171","author":"F Ramezani Tehrani","year":"2014","unstructured":"Ramezani Tehrani F, Minooee S, Azizi F. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study. Eur J Endocrinol. 2014;171(2):199\u2013207.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2719_CR47","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1530\/EJE-16-0775","volume":"175","author":"I Bo\u017ei\u0107-Anti\u0107","year":"2016","unstructured":"Bo\u017ei\u0107-Anti\u0107 I, Ili\u0107 D, Bjeki\u0107-Macut J, Bogavac T, Vojnovi\u0107-Milutinovi\u0107 D, Kastratovic-Kotlica B, et al. Lipid accumulation product as a marker of cardiometabolic susceptibility in women with different phenotypes of polycystic ovary syndrome. Eur J Endocrinol. 2016;175(6):551\u201360.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2719_CR48","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.metabol.2016.01.006","volume":"65","author":"B Echibur\u00fa","year":"2016","unstructured":"Echibur\u00fa B, Crisosto N, Maliqueo M, P\u00e9rez-Bravo F, de Guevara AL, Hern\u00e1ndez P, et al. Metabolic profile in women with polycystic ovary syndrome across adult life. Metabolism. 2016;65(5):776\u201382.","journal-title":"Metabolism"},{"issue":"11","key":"2719_CR49","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/aogs.12964","volume":"95","author":"D Glintborg","year":"2016","unstructured":"Glintborg D, Petersen MH, Ravn P, Hermann AP, Andersen M. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls. Acta Obstet Gynecol Scand. 2016;95(11):1235\u201343.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"2719_CR50","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/cen.12965","volume":"84","author":"S Ozler","year":"2016","unstructured":"Ozler S, Oztas E, Tokmak A, Ergin M, Isci E, Eren F, et al. The association of thiol\/disulphide homeostasis and lipid accumulation index with cardiovascular risk factors in overweight adolescents with polycystic ovary syndrome. Clin Endocrinol. 2016;84(4):516\u201323.","journal-title":"Clin Endocrinol"},{"issue":"4","key":"2719_CR51","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3109\/09513590.2015.1112785","volume":"32","author":"K Techatraisak","year":"2016","unstructured":"Techatraisak K, Wongmeerit K, Dangrat C, Wongwananuruk T, Indhavivadhana S. Measures of body adiposity and visceral adiposity index as predictors of metabolic syndrome among Thai women with PCOS. Gynecol Endocrinol. 2016;32(4):276\u201380.","journal-title":"Gynecol Endocrinol"},{"key":"2719_CR52","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejogrb.2016.06.022","volume":"204","author":"B \u00dcn","year":"2016","unstructured":"\u00dcn B, Dolap\u00e7\u0131o\u011flu KS, G\u00fcler Okyay A, \u015eahin H, Beyaz\u0131t A. Evaluation of hs-CRP and visseral adiposity index in patients with policystic ovary syndrome by clinical and laboratory findings. Eur J Obstet Gynecol Reprod Biol. 2016;204:16\u201320.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"2719_CR53","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s40618-016-0582-x","volume":"40","author":"U Durmus","year":"2017","unstructured":"Durmus U, Duran C, Ecirli S. Visceral adiposity index levels in overweight and\/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters. J Endocrinol Invest. 2017;40(5):487\u201397.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2719_CR54","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40618-016-0570-1","volume":"40","author":"FM Mario","year":"2017","unstructured":"Mario FM, Graff SK, Spritzer PM. Habitual physical activity is associated with improved anthropometric and androgenic profile in PCOS: a cross-sectional study. J Endocrinol Invest. 2017;40(4):377\u201384.","journal-title":"J Endocrinol Invest"},{"key":"2719_CR55","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejogrb.2017.05.014","volume":"214","author":"EN Tola","year":"2017","unstructured":"Tola EN, Yalcin SE, Dugan N. The predictive effect of inflammatory markers and lipid accumulation product index on clinical symptoms associated with polycystic ovary syndrome in nonobese adolescents and younger aged women. Eur J Obstet Gynecol Reprod Biol. 2017;214:168\u201372.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"2719_CR56","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/09513590.2017.1395835","volume":"34","author":"A Dawood","year":"2018","unstructured":"Dawood A, Alkafrawy N, Saleh S, Noreldin R, Zewain S. The relationship between IL-18 and atherosclerotic cardiovascular risk in Egyptian lean women with polycystic ovary syndrome. Gynecol Endocrinol. 2018;34(4):294\u20137.","journal-title":"Gynecol Endocrinol"},{"key":"2719_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.maturitas.2018.06.013","volume":"116","author":"E Vassilatou","year":"2018","unstructured":"Vassilatou E, Lafoyianni S, Vassiliadi DA, Ioannidis D, Paschou SA, Mizamtsidi M, et al. Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome. Maturitas. 2018;116:1\u20137.","journal-title":"Maturitas"},{"issue":"8","key":"2719_CR58","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1530\/EC-19-0243","volume":"8","author":"A Adamska","year":"2019","unstructured":"Adamska A, Polak AM, Krentowska A, \u0141ebkowska A, Hryniewicka J, Le\u015bniewska M, et al. Increased serum fetuin-B concentration is associated with HOMA-\u03b2 and indices of liver steatosis in women with polycystic ovary syndrome: a pilot study. Endocr Connect. 2019;8(8):1159\u201367.","journal-title":"Endocr Connect"},{"issue":"1","key":"2719_CR59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40618-018-0888-y","volume":"42","author":"M Calzada","year":"2019","unstructured":"Calzada M, L\u00f3pez N, Noguera JA, Mendiola J, Torres AM. Elevation of isoprostanes in polycystic ovary syndrome and its relationship with cardiovascular risk factors. J Endocrinol Invest. 2019;42(1):75\u201383.","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"2719_CR60","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1089\/met.2019.0019","volume":"17","author":"J Long","year":"2019","unstructured":"Long J, Li L, Wang F, Yang G, Cheng W, Wei J, et al. Screening for a simple and effective indicator of insulin resistance in Chinese reproductive-aged women, with the insulin clamp technique as a reference. Metab Syndr Relat Disord. 2019;17(8):423\u20139.","journal-title":"Metab Syndr Relat Disord"},{"key":"2719_CR61","doi-asserted-by":"crossref","unstructured":"Maidana P, Fritzler A, Mocarbel Y, Lana MBP, Gonz\u00e1lez D, Rosales M, et al. Association between vitamin d and adrenal parameters with metabolic and inflammatory markers in polycystic ovary syndrome. Sci Rep. 2019;9(1):3968.","DOI":"10.1038\/s41598-019-40653-z"},{"issue":"6","key":"2719_CR62","doi-asserted-by":"publisher","first-page":"420","DOI":"10.5468\/ogs.2019.62.6.420","volume":"62","author":"Z Tahergorabi","year":"2019","unstructured":"Tahergorabi Z, Salmani F, Jonaidabad SH, Behdani B, Yazdi P, Zardast M, et al. Association of serum levels of vascular endothelial growth factor and thrombospondin-1 to body mass index in polycystic ovary syndrome: a case-control study. Obstet Gynecol Sci. 2019;62(6):420\u20138.","journal-title":"Obstet Gynecol Sci"},{"issue":"4","key":"2719_CR63","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4103\/ijmr.IJMR_610_18","volume":"151","author":"S Chakraborty","year":"2020","unstructured":"Chakraborty S, Ganie MA, Masoodi I, Jana M, Gupta N, Sofi NY. Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndrome. Indian J Med Res. 2020;151(4):333\u201341.","journal-title":"Indian J Med Res"},{"key":"2719_CR64","doi-asserted-by":"crossref","unstructured":"Alissa EM, Algarni SA, Khaffji AJ, Al Mansouri NM. Association of diet diversity score with visceral adiposity in women with polycystic ovarian syndrome. Hum Nutr Metab. 2021;23:200116.","DOI":"10.1016\/j.hnm.2020.200116"},{"issue":"3","key":"2719_CR65","first-page":"BC11","volume":"15","author":"RH Babu","year":"2021","unstructured":"Babu RH, Nair RS, Chakrapani N. Lipid accumulation product as a marker of cardiovascular disease risk among women with polycystic ovarian syndrome- a hospital based case-control study. J Clin Diagn Res. 2021;15(3):BC11\u20135.","journal-title":"J Clin Diagn Res"},{"issue":"5","key":"2719_CR66","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s40519-020-00980-x","volume":"26","author":"B Ba\u015far G\u00f6kcen","year":"2021","unstructured":"Ba\u015far G\u00f6kcen B, Akdevelio\u011flu Y, Canan S, Bozkurt N. Evaluation of the relationship between serum ferritin and insulin resistance and visceral adiposity index (VAI) in women with polycystic ovary syndrome. Eat Weight Disord. 2021;26(5):1581\u201393.","journal-title":"Eat Weight Disord"},{"issue":"3","key":"2719_CR67","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.tjog.2021.03.017","volume":"60","author":"I Biyik","year":"2021","unstructured":"Biyik I, Erten O, Isiklar OO, Ince O, Soysal C, Berikten D, et al. Comparison of serum human Klotho levels and thiol\/disulfide homeostasis in women with polycystic ovary syndrome and in healthy women. Taiwan J Obstet Gynecol. 2021;60(3):487\u201391.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"2","key":"2719_CR68","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4274\/tjod.galenos.2021.39024","volume":"18","author":"MD \u00c7altekin","year":"2021","unstructured":"\u00c7altekin MD, Caniklioglu A, Yal\u00e7in SE, Kirmizi DA, Baser E, Yalva\u00e7 ES. DLK1 and Nesfatin-1 levels and the relationship with metabolic parameters in polycystic ovary syndrome: prospective, controlled study. Turk J Obstet Gynecol. 2021;18(2):124\u201330.","journal-title":"Turk J Obstet Gynecol"},{"issue":"7","key":"2719_CR69","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1530\/EC-21-0118","volume":"10","author":"V Guarnotta","year":"2021","unstructured":"Guarnotta V, Lucchese S, Mineo MI, Mangione D, Venezia R, Almasio PL, et al. Predictive factors of polycystic ovary syndrome in girls with precocious pubarche. Endocr Connect. 2021;10(7):796\u2013804.","journal-title":"Endocr Connect"},{"key":"2719_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/nu13082494","author":"M Ka\u0142u\u017cna","year":"2021","unstructured":"Ka\u0142u\u017cna M, Czlapka-Matyasik M, Bykowska-Derda A, Moczko J, Ruchala M, Ziemnicka K. Indirect predictors of visceral adipose tissue in women with polycystic ovary syndrome: a comparison of methods. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13082494.","journal-title":"Nutrients"},{"issue":"3","key":"2719_CR71","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4103\/jhrs.jhrs_12_21","volume":"14","author":"Z Naghshband","year":"2021","unstructured":"Naghshband Z, Kumar L, Mandappa S, Niranjana Murthy AS, Malini SS. Visceral adiposity index and lipid accumulation product as diagnostic markers of metabolic syndrome in South Indians with polycystic ovary syndrome. J Hum Reprod Sci. 2021;14(3):234\u201343.","journal-title":"J Hum Reprod Sci"},{"key":"2719_CR72","doi-asserted-by":"crossref","unstructured":"Farhadi-Azar M, Behboudi-Gandevani S, Rahmati M, Mahboobifard F, Pouya EK, Tehrani FR, et al. The prevalence of polycystic ovary syndrome, its phenotypes and cardio-metabolic features in a community sample of iranian population: tehran lipid and glucose study. Front Endocrinol. 2022;13:825528.","DOI":"10.3389\/fendo.2022.825528"},{"key":"2719_CR73","doi-asserted-by":"publisher","first-page":"204201882110666","DOI":"10.1177\/20420188211066699","volume":"13","author":"M Ka\u0142u\u017cna","year":"2022","unstructured":"Ka\u0142u\u017cna M, Czlapka-Matyasik M, Kompf P, Moczko J, Wachowiak-Ochma\u0144ska K, Janicki A, et al. Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2022;13:20420188211066700.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"9","key":"2719_CR74","first-page":"e29796","volume":"14","author":"P Sharma","year":"2022","unstructured":"Sharma P, Sarkar A, Kaur H, Gupta U, Kumar B. Visceral adiposity index as an indicator for menstrual disturbance, hormonal and metabolic dysfunction in polycystic ovarian syndrome. Cureus. 2022;14(9):e29796.","journal-title":"Cureus"},{"key":"2719_CR75","doi-asserted-by":"crossref","unstructured":"Bi\u00e7er NC, Ermis AA, Bas D. The role of different methods in defining cardiometabolic risk and metabolic syndrome in women with polycystic ovary syndrome. Life-Basel. 2023;13(10):1959.","DOI":"10.3390\/life13101959"},{"issue":"5","key":"2719_CR76","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000627","volume":"67","author":"GS Kogure","year":"2023","unstructured":"Kogure GS, Ribeiro VB, Mendes MC, Ferriani RA, Furtado CLM, Dos Reis RM. Dual-energy X-ray absorptiometry and adiposity index are sensitive methods to evaluate central fat accumulation in women with polycystic ovary syndrome and normal body mass index. Arch Endocrinol Metab. 2023;67(5):e000627.","journal-title":"Arch Endocrinol Metab"},{"issue":"1","key":"2719_CR77","first-page":"25","volume":"57","author":"RB De Melo Cavalcante","year":"2024","unstructured":"De Melo Cavalcante RB, Le\u00e3o LMCSM, Tavares ABW, Lopes KG, Kraemer-Aguiar LG. Fat distribution and its correlation with insulin resistance, androgen markers, and proinflammatory cytokines in polycystic ovary syndrome. Hormone Metab Res. 2024;57(1):25\u201332.","journal-title":"Hormone Metab Res."},{"issue":"9","key":"2719_CR78","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1007\/s43032-024-01532-9","volume":"31","author":"Y Feng","year":"2024","unstructured":"Feng Y, Li M, Li X, Tang Q, Li X, Ji X, et al. Characteristics of different obesity metabolic indexes and their correlation with insulin resistance in patients with Polycystic Ovary Syndrome. Reprod Sci. 2024;31(9):2829\u201335.","journal-title":"Reprod Sci"},{"issue":"2","key":"2719_CR79","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1515\/tjb-2023-0215","volume":"49","author":"A Yavuzcan","year":"2024","unstructured":"Yavuzcan A, Keyif B, Yavuzcan G, G\u00f6yn\u00fcmer G. Can triglyceride related indices be reliable markers in the assessment of polycystic ovarian syndrome? Turk J Biochem. 2024;49(2):259\u201365.","journal-title":"Turk J Biochem"},{"issue":"1","key":"2719_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-025-03617-2","volume":"25","author":"MA Ganie","year":"2025","unstructured":"Ganie MA, Malhotra N, Jabbar PK, Aggarwal S, Rozati R, Sahay R, et al. Cardiometabolic markers and serum AMH levels in PCOS: can AMH serve as a surrogate cardiometabolic marker? BMC Womens Health. 2025;25(1):106.","journal-title":"BMC Womens Health"},{"issue":"2","key":"2719_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2024.104447","volume":"50","author":"T Vulcan","year":"2025","unstructured":"Vulcan T, Iancu M, Procopciuc LM, Suciu TS, Filip GA. Association of vitamin D receptor gene polymorphisms, metabolic features and susceptibility to polycystic ovary syndrome: a preliminary study. Reprod Biomed Online. 2025;50(2):104447.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"2719_CR82","doi-asserted-by":"publisher","first-page":"513","DOI":"10.18203\/2320-1770.ijrcog20180164","volume":"7","author":"B Joshi","year":"2018","unstructured":"Joshi B, Lakhan T, Mukherji S, Patil A, Unisa S. Visceral adiposity index among young girls with PCOS and its association with phenotypes and metabolic risk. Int J Reprod Contracept Obstet Gynecol. 2018;7(2):513\u20138.","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"issue":"8","key":"2719_CR83","doi-asserted-by":"publisher","first-page":"664","DOI":"10.28982\/josam.755729","volume":"4","author":"G Adanas","year":"2020","unstructured":"Adanas G, \u00d6zgen G. The relation of visceral adiposity index and lipid accumulation product with metabolic, anthropometric, and hormonal parameters in patients with polycystic ovary syndrome. J Surg Med. 2020;4(8):664\u20138.","journal-title":"J Surg Med"},{"issue":"3","key":"2719_CR84","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/medicina61030424","volume":"61","author":"B Keyif","year":"2025","unstructured":"Keyif B, Yavuzcan A. Visceral and dysfunctional adiposity indices as predictors of insulin resistance and metabolic syndrome in women with polycystic ovary syndrome: a cross-sectional study. Medicina (B Aires). 2025;61(3):424.","journal-title":"Medicina (B Aires)"},{"issue":"1","key":"2719_CR85","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"ESHRE\/ASRM","year":"2004","unstructured":"ESHRE\/ASRM. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137.","journal-title":"Hum Reprod"},{"issue":"9","key":"2719_CR86","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602\u201318.","journal-title":"Hum Reprod"},{"issue":"11","key":"2719_CR87","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91(11):4237\u201345.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2719_CR88","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/09513590.2018.1519794","volume":"35","author":"G Anik Ilhan","year":"2019","unstructured":"Anik Ilhan G, Yildizhan B, Pekin T. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome. Gynecol Endocrinol. 2019;35(3):233\u20136.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"2719_CR89","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1089\/met.2020.0045","volume":"19","author":"SF de Medeiros","year":"2021","unstructured":"de Medeiros SF, de Medeiros MAS, Barbosa BB, Yamamoto MMW. The role of visceral adiposity index as predictor of metabolic syndrome in obese and nonobese women with polycystic ovary syndrome. Metab Syndr Relat Disord. 2021;19(1):18\u201325.","journal-title":"Metab Syndr Relat Disord"},{"issue":"8","key":"2719_CR90","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/oby.20096","volume":"21","author":"JY Oh","year":"2013","unstructured":"Oh JY, Sung YA, Lee HJ. The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome. Obesity. 2013;21(8):1690\u20134.","journal-title":"Obesity"},{"issue":"3","key":"2719_CR91","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/09513590.2015.1111327","volume":"32","author":"SH Zheng","year":"2016","unstructured":"Zheng SH, Li XL. Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS. Gynecol Endocrinol. 2016;32(3):177\u201383.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"2719_CR92","doi-asserted-by":"publisher","first-page":"E454","DOI":"10.1152\/ajpendo.00203.2004","volume":"288","author":"M Kabir","year":"2005","unstructured":"Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, Dea MK, et al. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab. 2005;288(2):E454\u201361.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"2719_CR93","doi-asserted-by":"publisher","first-page":"36091","DOI":"10.1038\/srep36091","volume":"6","author":"S-x Guo","year":"2016","unstructured":"Guo S-x, Zhang X-h, Zhang J-y, He J, Yan Y-z, Ma J-l, et al. Visceral adiposity and anthropometric indicators as screening tools of metabolic syndrome among low income rural adults in Xinjiang. Sci Rep. 2016;6(1):36091.","journal-title":"Sci Rep"},{"issue":"03","key":"2719_CR94","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1055\/s-0042-119032","volume":"125","author":"N Motamed","year":"2017","unstructured":"Motamed N, Khonsari M, Rabiee B, Ajdarkosh H, Hemasi G, Sohrabi M, et al. Discriminatory ability of visceral adiposity index (VAI) in diagnosis of metabolic syndrome: a population based study. Exp Clin Endocrinol Diabetes. 2017;125(03):202\u20137.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"7","key":"2719_CR95","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/humrep\/det105","volume":"28","author":"MC Amato","year":"2013","unstructured":"Amato MC, Guarnotta V, Forti D, Donatelli M, Dolcimascolo S, Giordano C. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment. Hum Reprod. 2013;28(7):1919\u201328.","journal-title":"Hum Reprod"},{"key":"2719_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-511X-10-183","volume":"10","author":"MC Amato","year":"2011","unstructured":"Amato MC, Giordano C, Pitrone M, Galluzzo A. Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis. 2011;10:1\u20138.","journal-title":"Lipids Health Dis"},{"key":"2719_CR97","first-page":"537","volume":"36","author":"M Amato","year":"2013","unstructured":"Amato M, Guarnotta V, Giordano C. Body composition assessment for the definition of cardiometabolic risk. J Endocrinol Invest. 2013;36:537\u201343.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2719_CR98","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/humupd\/dmr046","volume":"18","author":"ML Meyer","year":"2012","unstructured":"Meyer ML, Malek AM, Wild RA, Korytkowski MT, Talbott EO. Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(2):112\u201326.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2719_CR99","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s12020-019-01912-1","volume":"65","author":"X Huang","year":"2019","unstructured":"Huang X, Wang Q, Liu T, Pei T, Liu D, Zhu H, et al. Body fat indices as effective predictors of insulin resistance in obese\/non-obese polycystic ovary syndrome women in the Southwest of China. Endocrine. 2019;65(1):81\u20135.","journal-title":"Endocrine"},{"issue":"4","key":"2719_CR100","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/embo-reports\/kve071","volume":"2","author":"S Kersten","year":"2001","unstructured":"Kersten S. Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep. 2001 Apr;2(4):282\u20136.https:\/\/doi.org\/10.1093\/embo-reports\/kve071","journal-title":"EMBO Rep"},{"issue":"4","key":"2719_CR101","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"issue":"3","key":"2719_CR102","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7555\/JBR.30.20140111","volume":"30","author":"C Yuan","year":"2016","unstructured":"Yuan C, Liu X, Mao Y, Diao F, Cui Y, Liu J. Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study. J Biomed Res. 2016;30(3):197.","journal-title":"J Biomed Res"},{"issue":"1","key":"2719_CR103","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3109\/09513590.2011.583956","volume":"28","author":"EC Costa","year":"2012","unstructured":"Costa EC, de Ferezini Sa JC, Mafaldo Soares EM, Araujo Moura Lemos TM, de Oliveira Maranh\u00e3o TM, Dantas Azevedo G. Anthropometric indices of central obesity how discriminators of metabolic syndrome in Brazilian women with polycystic ovary syndrome. Gynecol Endocrinol. 2012;28(1):12\u20135.","journal-title":"Gynecol Endocrinol."},{"key":"2719_CR104","unstructured":"R aimi TH, Oluwayemi IO. Anthropometric Correlates and Prediction of Body Fat Measured by Bioelectric Impedance Analysis among Women. Ann Med Health Sci Res. 2017;7:32\u201335."},{"key":"2719_CR105","unstructured":"Organization WH. Obesity: preventing and managing the global epidemic: report of a WHO consultation. 2000."},{"issue":"3","key":"2719_CR106","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","volume":"16","author":"R Ross","year":"2020","unstructured":"Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR working group on visceral obesity. Nat Rev Endocrinol. 2020;16(3):177\u201389.","journal-title":"Nat Rev Endocrinol"},{"key":"2719_CR107","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.nut.2018.09.005","volume":"60","author":"D Shalini","year":"2019","unstructured":"Shalini D, Ponnalagu O, Bi X, Henry CJ. Is waist circumference more strongly associated with metabolic risk factors than waist-to-height ratio in Asians? Nutrition. 2019;60:30\u20134.","journal-title":"Nutrition"},{"issue":"6","key":"2719_CR108","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1017\/S0007114519003301","volume":"123","author":"S Gibson","year":"2020","unstructured":"Gibson S, Ashwell M. A simple cut-off for waist-to-height ratio (0\u00b7 5) can act as an indicator for cardiometabolic risk: recent data from adults in the health survey for England. Br J Nutr. 2020;123(6):681\u201390.","journal-title":"Br J Nutr"},{"issue":"5","key":"2719_CR109","doi-asserted-by":"publisher","first-page":"e0177175","DOI":"10.1371\/journal.pone.0177175","volume":"12","author":"MG Swainson","year":"2017","unstructured":"Swainson MG, Batterham AM, Tsakirides C, Rutherford ZH, Hind K. Prediction of whole-body fat percentage and visceral adipose tissue mass from five anthropometric variables. PLoS One. 2017;12(5):e0177175.","journal-title":"PLoS One"},{"issue":"1","key":"2719_CR110","first-page":"931402","volume":"2011","author":"K Knowles","year":"2011","unstructured":"Knowles K, Paiva L, Sanchez S, Revilla L, Lopez T, Yasuda M, et al. Waist circumference, body mass index, and other measures of adiposity in predicting cardiovascular disease risk factors among Peruvian adults. Int J Hypertens. 2011;2011(1):931402.","journal-title":"Int J Hypertens"},{"issue":"11","key":"2719_CR111","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1172\/JCI200422028","volume":"113","author":"S Klein","year":"2004","unstructured":"Klein S. The case of visceral fat: argument for the defense. J Clin Invest. 2004;113(11):1530\u20132.","journal-title":"J Clin Invest"},{"key":"2719_CR112","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3389\/fphys.2019.01607","volume":"10","author":"F Zatterale","year":"2019","unstructured":"Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C, et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol. 2019;10:1607.","journal-title":"Front Physiol"},{"issue":"2","key":"2719_CR113","doi-asserted-by":"publisher","first-page":"e06264","DOI":"10.1016\/j.heliyon.2021.e06264","volume":"7","author":"N Sukkriang","year":"2021","unstructured":"Sukkriang N, Chanprasertpinyo W, Wattanapisit A, Punsawad C, Thamrongrat N, Sangpoom S. Correlation of body visceral fat rating with serum lipid profile and fasting blood sugar in obese adults using a noninvasive machine. Heliyon. 2021;7(2):e06264.","journal-title":"Heliyon"},{"issue":"4","key":"2719_CR114","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1017\/S0007114521003585","volume":"128","author":"IMP Blagojevic","year":"2022","unstructured":"Blagojevic IMP, Vekic JZ, Macut DP, Ignjatovic SD, Miljkovic-Trailovic MM, Zeljkovic AR, et al. Overweight and obesity in polycystic ovary syndrome: association with inflammation, oxidative stress and dyslipidaemia. Br J Nutr. 2022;128(4):604\u201312.","journal-title":"Br J Nutr"},{"key":"2719_CR115","doi-asserted-by":"crossref","unstructured":"Ilie IR, Herdean AM, Herdean AI, Georgescu CE. Lipidomic biomarkers in polycystic ovary syndrome: An overview. InAnnales d'Endocrinologie. 2023;84(1):69\u201380.","DOI":"10.1016\/j.ando.2022.07.675"},{"issue":"3","key":"2719_CR116","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/pr.2013.229","volume":"75","author":"NM Al-Daghri","year":"2014","unstructured":"Al-Daghri NM, Al-Attas OS, Alokail M, Alkharfy K, Wani K, Amer OE, et al. Does visceral adiposity index signify early metabolic risk in children and adolescents?: association with insulin resistance, adipokines, and subclinical inflammation. Pediatr Res. 2014;75(3):459\u201363.","journal-title":"Pediatr Res"},{"key":"2719_CR117","doi-asserted-by":"crossref","unstructured":"Pasquali R, Pignatelli D. hyperandrogenism in women beyond polycystic ovary syndrome foreword. KARGER POSTFACH, CH-4009 BASEL, SWITZERLAND; 2019. p. VII-VIII.","DOI":"10.1159\/000496415"},{"issue":"8","key":"2719_CR118","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529\u201336.","journal-title":"Ann Intern Med"},{"key":"2719_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1279978","volume":"14","author":"W Han","year":"2023","unstructured":"Han W, Zhang M, Wang H, Yang Y, Wang L. Lipid accumulation product is an effective predictor of metabolic syndrome in non-obese women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2023;14:1279978.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2719_CR120","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF03401401","volume":"15","author":"D Macut","year":"2016","unstructured":"Macut D, Bo\u017ei\u0107 Anti\u0107 I, Bjeki\u0107-Macut J, Panidis D, Tziomalos K, Vojnovi\u0107 Milutinovi\u0107 D, et al. Lipid accumulation product is associated with metabolic syndrome in women with polycystic ovary syndrome. Hormones (Athens). 2016;15(1):35\u201344.","journal-title":"Hormones (Athens)"},{"issue":"4","key":"2719_CR121","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s00404-023-07328-7","volume":"309","author":"ALL Rocha","year":"2024","unstructured":"Rocha ALL, Ba\u00eata T, Nazareth IR, Costa JM, Caporalli JD, Oliveira MA, et al. The role of the visceral adiposity index in the assessment of metabolic syndrome of polycystic ovary syndrome patients: a new anthropometric index. Arch Gynecol Obstet. 2024;309(4):1643\u20139.","journal-title":"Arch Gynecol Obstet"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02719-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02719-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02719-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T15:33:20Z","timestamp":1759851200000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02719-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":121,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2719"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02719-y","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As a review article that did not involve human or animal subjects, this study did not require institutional review board approval. Nonetheless, the review protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) on 4\/23\/2025, under the code CRD420251037083 (URL: ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"311"}}